Fate Therapeutics Inc (FATE)
4.06
-0.04
(-0.98%)
USD |
NASDAQ |
May 03, 16:00
4.06
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Amicus Therapeutics Inc | 90.16% |
Sarepta Therapeutics Inc | 87.77% |
ADMA Biologics Inc | 42.06% |
Ocular Therapeutix Inc | 90.64% |
Viking Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -37.07% |
Return on Assets | -27.09% |
Return on Invested Capital | -37.07% |
Profit Margin (Quarterly) | -2.63K% |
Operating Margin (Quarterly) | -2.87K% |
Return on Net Operating Assets | -89.35% |